Long-acting insulin analogues for type 1 diabetes: An overview of systematic reviews and meta-analysis of randomized controlled trials

The relationship between HbA1c values and the occurrence of hypoglycemia as assessed by continuous glucose monitoring in patients with type 1 diabetes

(2016) Daisuke Tsujino et al.   Diabetology & Metabolic Syndrome

Systematic review and meta-analysis of randomized clinical trials comparing efficacy and safety outcomes of insulin glargine with NPH insulin, premixed insulin preparations or with insulin detemir in type 2 diabetes mellitus

(2015) Przemyslaw Rys et al.   ACTA DIABETOLOGICA

New Insulin Glargine 300 U/mL for the Treatment of Type 1 and Type 2 Diabetes Mellitus

(2015) Jennifer Goldman et al.   ANNALS OF PHARMACOTHERAPY

Comparison of the Pharmacokinetics and Pharmacodynamics of LY2963016 Insulin Glargine and EU- and US-Approved Versions of Lantus Insulin Glargine in Healthy Subjects: Three Randomized Euglycemic Clamp Studies

(2015) Helle Linnebjerg et al.   DIABETES CARE

Basal Insulin Regimens: Systematic Review, Network Meta-Analysis, and Cost - Utility Analysis for the National Institute For Health and Care Excellence (Nice) Clinical Guideline on Type 1 Diabetes Mellitus in Adults

(2015) D Dawoud et al.   VALUE IN HEALTH

The beneficial effect of insulin degludec on nocturnal hypoglycaemia and insulin dose in type 1 diabetic patients: a systematic review and meta-analysis of randomised trials

(2014) K. Dżygało et al.   ACTA DIABETOLOGICA

Insulin Analogs—Are They Worth It? Yes!

(2014) George Grunberger   DIABETES CARE

Effect of insulin analogues on risk of severe hypoglycaemia in patients with type 1 diabetes prone to recurrent severe hypoglycaemia (HypoAna trial): a prospective, randomised, open-label, blinded-endpoint crossover trial

(2014) Ulrik Pedersen-Bjergaard et al.   Lancet Diabetes & Endocrinology

Insulin Glargine in a Brazilian State: Should the Government Disinvest? An Assessment Based on a Systematic Review

(2014) Ana Luísa Caires de Souza et al.   Applied Health Economics and Health Policy

Evaluating principal surrogate endpoints with time-to-event data accounting for time-varying treatment efficacy

(2013) E. E. Gabriel et al.   BIOSTATISTICS

Insulin analogues versus human insulin in type 1 diabetes: direct and indirect meta-analyses of efficacy and safety

(2013) Andréia Cristina Conegero Sanches et al.   Brazilian Journal of Pharmaceutical Sciences

The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study at 30 Years: Overview

(2013) David M. Nathan et al.   DIABETES CARE

A comparison of insulin detemir and neutral protamine Hagedorn (isophane) insulin in the treatment of diabetes: a systematic review

(2013) B. M. Frier et al.   DIABETES OBESITY & METABOLISM

A randomized trial comparing the rate of hypoglycemia-assessed using continuous glucose monitoring-in 125 preschool children with type 1 diabetes treated with insulin glargine or NPH insulin (the PRESCHOOL study)

(2013) Thomas Danne et al.   PEDIATRIC DIABETES

Basal Supplementation of Insulin Lispro Protamine Suspension Versus Insulin Glargine and Detemir for Type 2 Diabetes: Meta-analysis of randomized controlled trials

(2012) K. Esposito et al.   DIABETES CARE

Prevalence of adults with type 1 diabetes who meet the goals of care in daily clinical practice: A nationwide multicenter study in Brazil

(2012) Marilia B. Gomes et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Insulin analogues in children with Type 1 diabetes: a 52-week randomized clinical trial

(2012) N. Thalange et al.   DIABETIC MEDICINE

Revisiting the efficacy of long-acting insulin analogues on adults with type 1 diabetes using mixed-treatment comparisons

(2011) Andréia Cristina Conegero Sanches et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Efficacy and safety of insulin analogues for the management of diabetes mellitus: a meta-analysis

(2009) S. R. Singh et al.   CANADIAN MEDICAL ASSOCIATION JOURNAL

Long-term efficacy and safety of insulin detemir compared to Neutral Protamine Hagedorn insulin in patients with Type 1 diabetes using a treat-to-target basal–bolus regimen with insulin aspart at meals: a 2-year, randomized, controlled trial

(2008) P. C. Bartley et al.   DIABETIC MEDICINE

Insulin Glargine Versus Intermediate-Acting Insulin as the Basal Component of Multiple Daily Injection Regimens for Adolescents with Type 1 Diabetes Mellitus

(2008) H. Peter Chase et al.   JOURNAL OF PEDIATRICS

Lower fasting blood glucose, glucose variability and nocturnal hypoglycaemia with glargine vs NPH basal insulin in subjects with Type 1 diabetes

(2008) G.B. Bolli et al.   NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES

A Randomized, Controlled Trial Comparing Twice-a-Day Insulin Glargine Mixed With Rapid-Acting Insulin Analogs Versus Standard Neutral Protamine Hagedorn (NPH) Therapy in Newly Diagnosed Type 1 Diabetes

(2008) K. Hassan et al.   PEDIATRICS